
CAS 875787-07-8
:LXR623
Description:
LXR623, with the CAS number 875787-07-8, is a synthetic compound that functions as a selective modulator of liver X receptors (LXRs), which are nuclear receptors involved in lipid metabolism, cholesterol homeostasis, and inflammation. This compound is primarily researched for its potential therapeutic applications in metabolic disorders, including atherosclerosis and diabetes. LXR623 exhibits characteristics such as high specificity for LXR subtypes, which allows it to modulate gene expression related to lipid metabolism without the broad side effects associated with non-selective LXR agonists. Its chemical structure typically includes functional groups that facilitate its interaction with the LXR proteins, promoting the transcription of target genes. Additionally, studies have indicated that LXR623 may influence the regulation of inflammatory pathways, making it a candidate for further investigation in the context of cardiovascular diseases. As with many experimental compounds, detailed pharmacokinetic and toxicological profiles are essential for understanding its safety and efficacy in clinical settings.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
2H-Indazole, 2-[(2-chloro-4-fluorophenyl)Methyl]-3-(4-fluorophenyl)-7-(trifluoroMethyl)-
CAS:Formula:C21H12ClF5N2Purity:98%Color and Shape:SolidMolecular weight:422.77842-(2-Chloro-4-Fluorobenzyl)-3-(4-Fluorophenyl)-7-(Trifluoromethyl)-2H-Indazole
CAS:2-(2-Chloro-4-Fluorobenzyl)-3-(4-Fluorophenyl)-7-(Trifluoromethyl)-2H-IndazolePurity:98%Molecular weight:422.78g/molLXR-623
CAS:Formula:C21H12ClF5N2Purity:>97.0%(GC)Color and Shape:White to Almost white powder to crystalMolecular weight:422.78LXR-623
CAS:<p>LXR-623 (WAY 252623) is an orally bioavailable and highly specifical synthetic modulator of LXR.</p>Formula:C21H12ClF5N2Purity:97.91% - 99.24%Color and Shape:SolidMolecular weight:422.78



